Status:
COMPLETED
Electrical Impedance Tomography in Fatty Liver Detection
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Gense Technologies Ltd.
Innovation and Technology Commission, Hong Kong
Conditions:
Non-Alcoholic Fatty Liver Disease
Eligibility:
All Genders
20-75 years
Brief Summary
Non-alcoholic fatty liver disease (NAFLD) is a condition where hepatocytes contain an abnormally high fat percentage. This condition is becoming increasingly common due to unhealthy food habits and se...
Detailed Description
Fatty liver disease is a condition where the hepatocytes (liver cells) contain more than 5% fat. This condition is becoming increasingly common due to unhealthy food habits and sedentary lifestyle. Si...
Eligibility Criteria
Inclusion
- Fatty liver patients diagnosed with fatty liver at S1, S2 and S3 stages, will be included.
- Control subjects will also be included (who do not have any known liver diseases). Healthy subjects will be chosen to be age and gender matched with case subjects.
Exclusion
- Subjects with previous liver diseases (in the control group) or any liver diseases other than fatty liver (in fatty liver patients).
- Subjects who had any kind of liver surgery or liver transplantation.
- Subjects with damaged skin on the abdomen.
- Subjects with implanted electronic devices.
- Subjects with spinal diseases/discomfort
- Subjects who had any recent abdominal surgery
- Pregnant women
- Ascites
- Heavy alcohol intake
- Metallic implants
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 29 2024
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT05189990
Start Date
January 1 2022
End Date
February 29 2024
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong
Hong Kong, Select A State Or Province, China, 0000